News

Researchers looked at how the vaccine affected patients' corneas - the clear front part of the eye that allows light to come ...
A new study suggests a potential link between the Pfizer COVID-19 vaccine and serious eye conditions like retinal vascular ...
EMA committee recommends marketing approval of Pfizer & BioNTech’s LP.8.1-adapted Covid-19 vaccine: New York Saturday, July 26, 2025, 10:00 Hrs [IST] Pfizer Inc. and BioNTech SE ...
Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.
By Brenda Goodman, CNN. The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech but that ...
Pfizer-BioNTech vaccine demonstrated 100% efficacy against COVID-19 in longer-term analysis, with no serious safety concerns identified; Data will support planned submissions for full regulatory ...
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that the European Medicines Agency's (EMA) Committee for ...
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...
The FDA has updated its warnings about potential cardiac risks associated with Pfizer and Moderna COVID-19 vaccines, particularly focusing on young men. Discover essential information about the latest ...
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose ...
Pfizer CEO Dr. Albert Bourla joined “GMA3: What You Need To Know” Monday to discuss the drug-maker's coronavirus vaccine after early analysis shows it to be 90% effective at preventing COVID-19.
Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to 202 ...